Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention
- Nucala (mepolizumab) is the first treatment to show a significant reduction in flares for patients with Hypereosinophilic Syndrome (HES)
- EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV
Tweets from GSK
-
GSK @GSK
Hear from Johanna, our R&D Lead for Smokers' Health at GSK Consumer Healthcare, who has the ultimate motivation to help every patient #LiveEveryBreath. gsk.com/en-gb/careers/…
about 1 hour ago
-
GSK @GSK
We’re delighted that Allan Saul, GVGH Director, has been nominated as an Honorary International Fellow of @ASTMH. This is great recognition of his continued contribution to progressing science for #globalhealth.
about 22 hours ago -
GSK @GSK
Today is 🌏 World COPD Day. Hear from caregivers and healthcare professionals on how we can help people living with COPD.#LiveEveryBreathh#AllTogetherro
about 2 days ago
